Astragaloside IV Reduces OxLDL-Induced BNP Overexpression by Regulating HDAC

Figure 5

iNOS levels in cells of each group. The levels of iNOS in HL-1 cells in blank control group, OxLDL intervention group, OxLDL + low dose astragaloside IV (12.5 µM) treatment group, and OxLDL + high-dose astragaloside IV (50 µM) treatment group (indicates  < 0.001; NS: no significance; n = 5).